Skip to content

Author

Christine Rehm

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

A phase III randomized study: Immunogenicity and safety of a quadrivalent meningococcal conjugate vaccine in healthy adults, adolescents, and children in India and healthy adolescents and children in South Africa.

BACKGROUND MenACYW-TT is a quadrivalent meningococcal conjugate vaccine approved for individuals aged ≥6 weeks. This Phase III study evaluated the immunogenicity and safety of a single dose of MenACYW-TT versus MenACYW-DT and MenPS-ACWY in healthy adults, adolescents, and children in India and in healthy adolescents an...

Ashish Bavdekar, D. Chansinghakul, Ravi Mandyam Dhati et al. · 0 citations
Clinical trial Open access Aug 2026

Safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in USA and Puerto Rico: Results from a Phase III, randomized, active-controlled study

This study supports the safety profile of MenACYW-TT in infants and toddlers aged ≥ 6 weeks and overall well tolerated, and safety profiles were comparable.

Abraham Moskow, Sandeep Gupta, M. Dhingra et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.